Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East
Authors:
- Walid FarajWFWalid Faraj
- Nigel HeatonNHNigel Heaton
- Mohammad RelaMRMohammad Rela
- Ala I. ShararaASAla I. Sharara
- 26 November 2004
- journal article
- case report
- Published by Frontiers Media SA in Transplant International
- Vol. 17 (11) , 735-739
Abstract
Familial hypercholesterolemia (FH) is an autosomal dominant inherited metabolic disorder resulting in advanced vascular atherosclerosis and premature death, primarily from coronary artery disease. The primary defect is a mutation in the gene encoding for the plasma LDL receptor located on the short arm of chromosome 19. Liver transplantation is currently the most effective method of treating this disorder. Living-related liver transplantation (LRLT) has become an excellent modality for treating children, including those with inherited metabolic diseases. In this paper, we describe the first report of a LRLT for familial hypercholesterolemia and review FH and the role of liver transplantation.Keywords
This publication has 16 references indexed in Scilit:
- Therapeutic apheresis in renal and metabolic diseasesJournal of Clinical Apheresis, 2000
- Liver transplantation for homozygous familial hypercholesterolaemia.Archives of Disease in Childhood, 1995
- Lipids and Lipoprotein Changes After Heart and Liver Transplantation in a Patient with Homozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1988
- Predictors of total and low-density lipoprotein cholesterol change after partial ileal bypassThe American Journal of Surgery, 1988
- Familial hypercholesterolaemiaJournal of the Royal Society of Medicine, 1987
- Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1984
- HEART-LIVER TRANSPLANTATION IN A PATIENT WITH FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1984
- Effects and side-effects of partial ileal by-pass surgery for familial hypercholesterolaemia.Gut, 1982
- Treatment of homozygous familial hypercholesterolaemia with portacaval shuntAtherosclerosis, 1982
- Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of CholesterolProceedings of the National Academy of Sciences, 1973